Clinical Trial to Evaluate Pharmacokinetic Characteristics of MIT-001 After SC Administration in Healthy Subjects
Clinical trial NCT05389696 · COMPLETED
Trial details
- NCT number
- NCT05389696
- Sponsor
- MitoImmune Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2023-02-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.